NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

視網膜疾病治療的全球市場:各類型,各劑型,各流通管道的預測(到2025年)- COVID-19累積的影響

Retinal Disorder Treatment Market Research Report by Type, by Dosage Form, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001113
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
視網膜疾病治療的全球市場:各類型,各劑型,各流通管道的預測(到2025年)- COVID-19累積的影響 Retinal Disorder Treatment Market Research Report by Type, by Dosage Form, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

全球視網膜疾病治療的市場規模預測將從2020年的67億2,896萬美元,擴大到2025年末的98億4,772萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供全球視網膜疾病治療市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,類型·劑型·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 各類型市場展望
  • 各劑型市場展望
  • 各流通管道市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各類型市場

  • 糖尿病視網膜病變
  • 黃斑部病變
    • 乾性黃斑部病變
    • 濕性黃斑部病變

第7章 各劑型市場

  • 膠囊·錠
  • 眼藥
  • 眼科用液劑
  • 凝膠
  • 軟膏

第8章 各流通管道市場

  • 醫院藥局
  • 線上藥局
  • 零售藥局

第9章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第13章 企業簡介

  • AbbVie Inc.
  • Abeona Therapeutics
  • Apellis Pharmaceuticals
  • Applied Genetic Technologies Corporation,
  • Bausch & Lomb, Inc.
  • Bayer AG
  • Bluebird bio Inc
  • F. Hoffmann-La Roche AG
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Graybug Vision, Inc.
  • Kubota Pharmaceutical Holdings Co., Ltd
  • Novartis International AG
  • ONL Therapeutics, Inc.
  • Opthea
  • Oxford BioMedica PLC
  • Oxurion NV
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Spark Therapeutics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Transgene SA

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-CA17E905E6FD

The Global Retinal Disorder Treatment Market size was estimated at USD 6,728.96 Million in 2020 and expected to reach USD 7,295.13 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.75% to reach USD 11,132.16 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Retinal Disorder Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type , the Retinal Disorder Treatment Market was studied across Diabetic Retinopathy and Macular Degeneration. The Macular Degeneration is further studied across Dry Macular Degeneration and Wet Macular Degeneration.

Based on Dosage Form, the Retinal Disorder Treatment Market was studied across Capsules & Tablets, Eye Drops, Eye Solutions, Gels, and Ointments.

Based on Distribution Channel , the Retinal Disorder Treatment Market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.

Based on Geography, the Retinal Disorder Treatment Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Retinal Disorder Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Retinal Disorder Treatment Market, including AbbVie Inc., Abeona Therapeutics, Apellis Pharmaceuticals, Applied Genetic Technologies Corporation,, Bausch & Lomb, Inc., Bayer AG, Bluebird bio Inc, F. Hoffmann-La Roche AG, Genentech, Inc., GlaxoSmithKline PLC, Graybug Vision, Inc., Kubota Pharmaceutical Holdings Co., Ltd, Novartis International AG, ONL Therapeutics, Inc., Opthea, Oxford BioMedica PLC, Oxurion NV, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Spark Therapeutics, Inc., Takeda Pharmaceutical Company Limited, and Transgene SA.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Retinal Disorder Treatment Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Retinal Disorder Treatment Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Retinal Disorder Treatment Market?
  • 4. What is the competitive strategic window for opportunities in the Global Retinal Disorder Treatment Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Retinal Disorder Treatment Market?
  • 6. What is the market share of the leading vendors in the Global Retinal Disorder Treatment Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Retinal Disorder Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. Dosage Form Outlook
  • 3.5. Distribution Channel Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing funding by regulatory bodies for research on ocular disorders
      • 5.1.1.2. Increasing prevalence of retinal disorders globally
      • 5.1.1.3. Rising elderly population coupled with macular degeneration
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in research and development activities
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations and advancements in treatments
      • 5.1.3.2. Growing strategic collaborations and commercialization of novel products
    • 5.1.4. Challenges
      • 5.1.4.1. Probable complications in the eye
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Retinal Disorder Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Diabetic Retinopathy
  • 6.3. Macular Degeneration
    • 6.3.1. Dry Macular Degeneration
    • 6.3.2. Wet Macular Degeneration

7. Retinal Disorder Treatment Market, by Dosage Form

  • 7.1. Introduction
  • 7.2. Capsules & Tablets
  • 7.3. Eye Drops
  • 7.4. Eye Solutions
  • 7.5. Gels
  • 7.6. Ointments

8. Retinal Disorder Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Online Pharmacy
  • 8.4. Retail Pharmacy

9. Americas Retinal Disorder Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Retinal Disorder Treatment Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Retinal Disorder Treatment Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AbbVie Inc.
  • 13.2. Abeona Therapeutics
  • 13.3. Apellis Pharmaceuticals
  • 13.4. Applied Genetic Technologies Corporation,
  • 13.5. Bausch & Lomb, Inc.
  • 13.6. Bayer AG
  • 13.7. Bluebird bio Inc
  • 13.8. F. Hoffmann-La Roche AG
  • 13.9. Genentech, Inc.
  • 13.10. GlaxoSmithKline PLC
  • 13.11. Graybug Vision, Inc.
  • 13.12. Kubota Pharmaceutical Holdings Co., Ltd
  • 13.13. Novartis International AG
  • 13.14. ONL Therapeutics, Inc.
  • 13.15. Opthea
  • 13.16. Oxford BioMedica PLC
  • 13.17. Oxurion NV
  • 13.18. Pfizer, Inc.
  • 13.19. Regeneron Pharmaceuticals, Inc.
  • 13.20. Santen Pharmaceutical Co., Ltd.
  • 13.21. Spark Therapeutics, Inc.
  • 13.22. Takeda Pharmaceutical Company Limited
  • 13.23. Transgene SA

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2020 (USD MILLION)
  • FIGURE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2020 (USD MILLION)
  • FIGURE 5. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2026
  • FIGURE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DRY MACULAR DEGENERATION, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DRY MACULAR DEGENERATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY WET MACULAR DEGENERATION, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY WET MACULAR DEGENERATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (%)
  • FIGURE 20. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2026
  • FIGURE 22. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CAPSULES & TABLETS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CAPSULES & TABLETS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE DROPS, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE DROPS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE SOLUTIONS, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE SOLUTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY GELS, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY GELS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY OINTMENTS, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2020 VS 2026 (%)
  • FIGURE 33. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2020 VS 2026 (USD MILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2026
  • FIGURE 35. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 42. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 44. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. CALIFORNIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. FLORIDA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. ILLINOIS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. NEW YORK RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. OHIO RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. PENNSYLVANIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. TEXAS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 57. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 59. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 68. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 70. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. GLOBAL RETINAL DISORDER TREATMENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 82. GLOBAL RETINAL DISORDER TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 83. GLOBAL RETINAL DISORDER TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 84. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RETINAL DISORDER TREATMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL RETINAL DISORDER TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DIABETIC RETINOPATHY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY MACULAR DEGENERATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DRY MACULAR DEGENERATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY WET MACULAR DEGENERATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY CAPSULES & TABLETS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE DROPS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY EYE SOLUTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CALIFORNIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CALIFORNIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CALIFORNIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. FLORIDA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. FLORIDA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. FLORIDA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ILLINOIS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ILLINOIS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ILLINOIS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. NEW YORK RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. NEW YORK RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. NEW YORK RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. OHIO RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. OHIO RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. OHIO RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PENNSYLVANIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PENNSYLVANIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PENNSYLVANIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. TEXAS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. TEXAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. TEXAS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ASIA-PACIFIC RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CHINA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. INDONESIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. JAPAN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. MALAYSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. PHILIPPINES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SOUTH KOREA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. THAILAND RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. FRANCE RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. GERMANY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. ITALY RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. NETHERLANDS RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. QATAR RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. RUSSIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SAUDI ARABIA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SOUTH AFRICA RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. SPAIN RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED ARAB EMIRATES RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY TYPE , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. UNITED KINGDOM RETINAL DISORDER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. GLOBAL RETINAL DISORDER TREATMENT MARKET: SCORES
  • TABLE 125. GLOBAL RETINAL DISORDER TREATMENT MARKET: BUSINESS STRATEGY
  • TABLE 126. GLOBAL RETINAL DISORDER TREATMENT MARKET: PRODUCT SATISFACTION
  • TABLE 127. GLOBAL RETINAL DISORDER TREATMENT MARKET: RANKING
  • TABLE 128. GLOBAL RETINAL DISORDER TREATMENT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 129. GLOBAL RETINAL DISORDER TREATMENT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 130. GLOBAL RETINAL DISORDER TREATMENT MARKET: MERGER & ACQUISITION
  • TABLE 131. GLOBAL RETINAL DISORDER TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 132. GLOBAL RETINAL DISORDER TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 133. GLOBAL RETINAL DISORDER TREATMENT MARKET: INVESTMENT & FUNDING
  • TABLE 134. GLOBAL RETINAL DISORDER TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 135. GLOBAL RETINAL DISORDER TREATMENT MARKET: LICENSE & PRICING
  • TABLE 136. GLOBAL RETINAL DISORDER TREATMENT MARKET: CONTACT DETAILS